期刊文献+

云南省药品制造行业人才现状分析

Analysis on Personnel Status in Pharmaceutical Manufacturing Industry of Yunnan Province
下载PDF
导出
摘要 目的了解云南省药品生产企业高层及生产质量管理人员专业素质情况,为促进药品制造行业的发展提供参考与建议。方法通过发放调查问卷的方式,收集并分析云南省药品制造行业人员的学历及专业情况。结果与结论基层生产人员的学历及药学专业背景有待提升与强化,企业应注重岗位继续教育与培训。 Objective To analyze the professional level of senior management and production quality management personnel in pharma- ceutical companiesof Yunnan Province, and provide references for the development of the pharmaceutical manufacturing industry. Methods The major status of professional level of the personnel in Yunnan pharmaceutical manufacturing industry was collected by questionnaires. Results and Conclusion The education and professional medical background should be improved and enhanced in the basic level personnel,and the companies should pay more attention tocontinuing education and training.
作者 王丹 周玲
出处 《中国药业》 CAS 2016年第18期16-18,共3页 China Pharmaceuticals
关键词 药品生产企业 生产人员 质量管理人员 药品生产质量管理规范 pharmaceutical manufacturing company production personnel quality management personnel GMP
  • 相关文献

参考文献10

二级参考文献43

  • 1游丹,陈瑜娜.医药企业GMP管理中人员培训的重要性[J].云南科技管理,2006,19(3):37-38. 被引量:6
  • 2FDA. WL : 320-07- 02, FDA's elect ronic freedom of infor marion reading room-warning letters and responses [EB/OL ] . [ 2007-09-06 ] . http: //www. fda. gov/cder/warn/2007/ 320-07-02- pdf.
  • 3FDA. WL : Guangdong Pharmaceutical Factory. FDA's electronic freedom of information reading room-warning letters and responses [ EB/OL ] . [ 1997-12-10 ] . http: //www.fda.gov/cder/warn/dec97/guangdong 121097. pdf.
  • 4FDA. WL : Tianjin Pharmaceutical Corp. FDA s electronic freedom of information reading room-warning letters and responses[EB/OL].[1997-12-30 ] . http: //www. fda.gov/ cder/warn/dec97/123097t.pdf.
  • 5国家食品药品监督管理局.关于印发药品GMP认证检查评定标准的通知[Z].国食药监安[2007]648号,2007.
  • 6FDA. Current Good Manufacturing Practice For Finished Pharmaceuticals [S]. Code Of Federal Regulations Title 21 Volume 4 PART 211, 2004: 5-5.
  • 7EMEA. Directive 2001/83/ Ec Of The European Parliament And Of The Council of 6 November 2001 on the Community code relating to medicinal products for human use [S] . Official Journal of the European Communities, 2001 : 83-85.
  • 8EMEA. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use-chapter2 [ S]. European Commission, 2005 : chapter2.
  • 9黄炳良,邓发.当前药品从业人员培训存在的问题与对策[ EB/OL ] . [ 2006-07-11 ] . http : //www. gxfda.gov.cn/ webportal/portal.po? UID = DWV1_WOULD_URL_179566&TOC = COLUMN_179566&OBJ = 228063.
  • 10药晶生产质鼍管理规范[S].卫生部令第27号,1992.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部